IGC Pharma, Inc.
IGC- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001326205
No open-market purchases or sales by IGC Pharma, Inc. insiders were filed in the last 90 days; 36 institutions reported holding it in 13F filings for Q2 2026, worth $1.41M in total; no superinvestor holds it.
Q4 2021 vs. Q3 2021
How the institutions holding IGC Pharma, Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Q4 2021 | Change |
|---|---|---|---|
| Holders | 32 | 29 | −3 |
| Shares | 5.34M | 6.22M | +887.9K (+16.6%) |
| Value | $7.90M | $6.07M | −$1.83M (−23.1%) |
New holders (3)
Institutions that held IGC Pharma, Inc. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Jane Street Group, LLC | 14,430 | $14.0K | 0.00% |
| FNY Investment Advisers, LLC | 12,000 | $11.0K | 0.01% |
| Tower Research Capital LLC (TRC) | 396 | $0 | 0.00% |
Sold out (6)
Institutions that held IGC Pharma, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Renaissance Technologies LLC | 436,800 | $646.0K |
| Marshall Wace, LLP | 20,750 | $31.0K |
| Two Sigma Securities, LLC | 19,866 | $29.0K |
| Group One Trading, L.P. | 12,521 | $19.0K |
| HRT Financial LP | 12,749 | $18.0K |
| Better Money Decisions, LLC | 425 | $1.00K |